BIRMINGHAM, Ala. (WIAT) – Most of us refer to it as the common cold and for most of us it’s no big deal.
But for new born babies the Respiratory Syncytial Virus, or RSV, is the leading cause of hospitalization during their first year of life.
Nearly 100% of babies contact this common seasonal virus by age 2. But, premature babies are twice as likely to become hospitalized from the virus.
Recently a committee within the American Academy of Pediatrics issued new guidance which dramatically reduces eligibility for a preventive therapy often given to babies at high-risk for RSV.
Neonatologist Dr. Mitchell Goldstein spoke with us about the restrictions. “What has happened is the American Academy of Pediatrics has greatly restricted the eligibility to babies who are under 29 weeks gestation ”
The American Academy of Pediatrics changed its recommendation following a new report released last month that shows advances in neonatal care have improved mortality in premature births.
The study also shows that RSV preventative treatments alone do not significantly alter mortality rates.
You can read more about the American Academy of Pediatrics findings by clicking here.
For additional reading regarding Dr. Goldstein’s concerns click here.